Canadians will be paying the second-highest drug prices outside the U.S. without changes to federal rules on costs, warns a federal regulator. Data show Canadians already pay from 10 to 30 percent more for comparable drugs than other countries: “We have been creeping up”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
